The manifold significant events of 2022 will etch the year in the memories of many. Some will recall it as the year that marked the end of the COVID-19 pandemic, while others will remember the soaring egg prices and never-ending price hikes. In coming years, the historic inflation witnessed in 2022 could potentially also be remembered as a catalyst for changes in drug development that altered the types of drugs receiving investments and being brought to market.
Implementing the appropriate laboratory instrumentation to support therapeutic development is crucial to the process of drug discovery. Life science and analytical instrumentation facilitates pharmaceutical R&D throughout these stages. SDi has observed the dynamics of the pharma/bio sector demand for instrumentation to support innovative biologics, small molecule drugs, regenerative pharmaceuticals, and biopharmaceuticals. Most of these drug […]
